# Minerva Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/minerva-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Santa Clara, US
- Website: www.minervasurgical.com
- Total disclosed funding: $93M
- Latest round: Series D (Dec 23, 2015)
- Investors on record: 3

## About

Based in California, US, and founded in 2008 by founders David M. Clapper (CEO) and Csaba Truckai, Minerva Surgical, Inc. operates as a medical device developer that treats abnormal uterine bleeding. The first product from the firm, the Minerva ES, was released in 2015. In December 2016, the company raised USD 16.72 million in funding. In 2020, Minerva Surgical acquired three additional devices for the treatment of AUB, such as Symphion, Genesys HTA, and Resectr. As of October 2021, Minerva Surgical shares began trading on the Nasdaq Global Market under the ticker symbol "UTRS.

Minerva Surgical, Inc.'s devices such as Minerva ES, Symphion, Genesys HTA, and Resectr support the endometrial lining of the uterus in premenopausal women who have menorrhagia due to various causes and have finished childbearing, allowing healthcare providers to give women, ideas to take efficient management of their menstrual cycle.

The company generates its revenue by marketing and selling its products through a direct sales force in the US. Minerva Surgical earned USD 52 million in revenue for the fiscal year ending June 2021.

## Funding rounds

- Series D, Dec 23, 2015, $15M — New Enterprise Associates, Versant Ventures, Vivo Capital
- Series D, Sep 12, 2014, $26M — New Enterprise Associates, Versant Ventures
- Series D, Dec 19, 2012, $20M — Versant Ventures
- Series C, May 18, 2011, $26M — New Enterprise Associates, Versant Ventures
- Series B, Feb 12, 2010, $6M — New Enterprise Associates

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B, Series C, Series D
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series C, Series D
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series D